Literature DB >> 29248656

Myocardial Fibrosis in Competitive Triathletes Detected by Contrast-Enhanced CMR Correlates With Exercise-Induced Hypertension and Competition History.

Enver Tahir1, Jitka Starekova1, Kai Muellerleile2, Alexandra von Stritzky2, Julia Münch2, Maxim Avanesov1, Julius M Weinrich1, Christian Stehning3, Sebastian Bohnen2, Ulf K Radunski2, Eric Freiwald4, Stefan Blankenberg2, Gerhard Adam1, Axel Pressler5, Monica Patten2, Gunnar K Lund6.   

Abstract

OBJECTIVES: This study analyzed the presence of myocardial fibrosis detected by late gadolinium-enhancement (LGE) cardiac magnetic resonance (CMR) in correlation with the performance of competitive triathletes objectified by an exercise test and individual competition history.
BACKGROUND: Myocardial fibrosis detected by LGE CMR has been reported to occur in 0% to 50% of asymptomatic athletes. However, the cause and mechanisms of myocardial fibrosis are unclear.
METHODS: Eighty-three asymptomatic triathletes undergoing >10 training h per week (43 ± 10 years of age; 65% male) and 36 sedentary controls were studied by using LGE and extracellular volume (ECV) CMR. Parameters of physical fitness were measured by spiroergometry. Triathletes reported their lifetime competition results.
RESULTS: LGE CMR revealed focal nonischemic myocardial fibrosis in 9 of 54 (17%) male triathletes (LGE+) but in none of the female triathletes (p < 0.05). LGE+ triathletes had higher peak exercise systolic blood pressure (213 ± 24 mm Hg) than LGE- triathletes (194 ± 26 mm Hg; p < 0.05). Furthermore, left ventricular mass index was higher in LGE+ triathletes (93 ± 7 g/m2) than in LGE- triathletes (84 ± 11 g/m2; p < 0.05). ECV in LGE- myocardium was higher in LGE+ triathletes (26.3 ± 1.8%) than in LGE- triathletes (24.4 ± 2.2%; p < 0.05). LGE+ triathletes completed longer cumulative distances in swimming and cycling races and participated more often in middle and Iron Man distances than LGE- triathletes. A cycling race distance of >1,880 km completed during competition had the highest accuracy to predict LGE, with an area under the curve value of 0.876 (p < 0.0001), resulting in high sensitivity (89%) and specificity (79%). Multivariate analysis identified peak exercise systolic blood pressure (p < 0.05) and the swimming race distance (p < 0.01) as independent predictors of LGE presence.
CONCLUSIONS: Myocardial fibrosis in asymptomatic triathletes seems to be associated with exercise-induced hypertension and the race distances. There appears to be a safe upper limit, beyond which exercise may result in myocardial fibrosis.
Copyright © 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  LV hypertrophy; T1 and T2 mapping; athletes heart; cardiac MR; extracellular volume; late gadolinium enhancement; myocardial fibrosis

Mesh:

Substances:

Year:  2017        PMID: 29248656     DOI: 10.1016/j.jcmg.2017.09.016

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN: 1876-7591


  35 in total

1.  Diagnostic yield of hypertrophic cardiomyopathy in first-degree relatives of decedents with idiopathic left ventricular hypertrophy.

Authors:  Gherardo Finocchiaro; Harshil Dhutia; Belinda Gray; Bode Ensam; Stathis Papatheodorou; Chris Miles; Aneil Malhotra; Zeph Fanton; Paulo Bulleros; Tessa Homfray; Adam A Witney; Nicholas Bunce; Lisa J Anderson; James S Ware; Rajan Sharma; Maite Tome; Elijah R Behr; Mary N Sheppard; Michael Papadakis; Sanjay Sharma
Journal:  Europace       Date:  2020-04-01       Impact factor: 5.214

Review 2.  The effects of endurance exercise on the heart: panacea or poison?

Authors:  Gemma Parry-Williams; Sanjay Sharma
Journal:  Nat Rev Cardiol       Date:  2020-03-09       Impact factor: 32.419

Review 3.  Cardiac Imaging in the Athlete: Shrinking the "Gray Zone".

Authors:  Mario R Caruso; Lohit Garg; Matthew W Martinez
Journal:  Curr Treat Options Cardiovasc Med       Date:  2020-02-03

4.  Diffusion tensor imaging combined with T2 mapping to quantify changes in the skeletal muscle associated with training and endurance exercise in competitive triathletes.

Authors:  S Keller; J Yamamura; J Sedlacik; Z J Wang; P Gebert; J Starekova; E Tahir
Journal:  Eur Radiol       Date:  2020-01-17       Impact factor: 5.315

Review 5.  Reference ranges ("normal values") for cardiovascular magnetic resonance (CMR) in adults and children: 2020 update.

Authors:  Nadine Kawel-Boehm; Scott J Hetzel; Bharath Ambale-Venkatesh; Gabriella Captur; Christopher J Francois; Michael Jerosch-Herold; Michael Salerno; Shawn D Teague; Emanuela Valsangiacomo-Buechel; Rob J van der Geest; David A Bluemke
Journal:  J Cardiovasc Magn Reson       Date:  2020-12-14       Impact factor: 5.364

Review 6.  Could Repeated Cardio-Renal Injury Trigger Late Cardiovascular Sequelae in Extreme Endurance Athletes?

Authors:  Johannes Burtscher; Paul-Emmanuel Vanderriele; Matthieu Legrand; Hans-Georg Predel; Josef Niebauer; James H O'Keefe; Grégoire P Millet; Martin Burtscher
Journal:  Sports Med       Date:  2022-07-18       Impact factor: 11.928

Review 7.  Arrhythmogenesis of Sports: Myth or Reality?

Authors:  Saad Fyyaz; Michael Papadakis
Journal:  Arrhythm Electrophysiol Rev       Date:  2022-04

Review 8.  Cardiovascular Care of Masters Athletes.

Authors:  Timothy W Churchill; Aaron L Baggish
Journal:  J Cardiovasc Transl Res       Date:  2020-03-18       Impact factor: 4.132

9.  Blood Pressure-Lowering Therapy.

Authors:  Isabella Sudano; Elena Osto; Frank Ruschitzka
Journal:  Handb Exp Pharmacol       Date:  2022

10.  Multi-parametric assessment of left ventricular hypertrophy using late gadolinium enhancement, T1 mapping and strain-encoded cardiovascular magnetic resonance.

Authors:  Sorin Giusca; Henning Steen; Moritz Montenbruck; Amit R Patel; Burkert Pieske; Jennifer Erley; Sebastian Kelle; Grigorios Korosoglou
Journal:  J Cardiovasc Magn Reson       Date:  2021-07-12       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.